Cite
HARVARD Citation
Gaziano, J. et al. (2018). Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. Lancet. 392 (10152), pp. 1036-1046. [Online].